Increased plasma levels of soluble TNF receptor i in patients with bipolar disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 261, Issue 2, 2011, Pages 139-143

  Barbosa, Izabela Guimarães ^a,b   Huguet, Rodrigo Barreto ^a,b   Mendonça, Vanessa Amaral ^a   Sousa, Lirlândia Pires ^a   Neves, Fernando Silva ^a   Bauer, Moisés Evandro ^c   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital Governador Israel Pinheiro   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bipolar disorder; Cytokines; Inflammation; Soluble TNF receptors; TNF alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; YOUNG MANIA RATING SCALE;

ADULT; AGE FACTORS; AGED; BIPOLAR DISORDER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952243496     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-010-0116-z     Document Type: Article

References (26)

1. AB Cunha AC Andreazza FA Gomes BN Frey LE da Silveira CA Gonçalves F Kapczinski 2008 Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder Eur Arch Psychiatry Clin Neurosci 258 5 300 304 18297417 10.1007/s00406-007-0797-0
2. BI Goldstein DE Kemp JK Soczynska RS McIntyre 2009 Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature J Clin Psychiatry 70 8 1078 1090 19497250 10.4088/JCP.08r04505
3. N Müller MJ Schwarz 2008 A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depressio (Pubitemid 351758763)
4. DJ Kupfer 2005 The increasing medical burden in bipolar disorder JAMA 293 2528 2530 1:CAS:528:DC%2BD2MXksFWktrY%3D 15914754 10.1001/jama.293.20.2528 (Pubitemid 40705735)
5. E Brietzke F Kapczinski 2008 TNF-alpha as a molecular target in bipolar disorder Prog Neuropsychopharmacol Biol Psychiatry 32 6 1355 1361 1:CAS:528:DC%2BD1cXptVeqsro%3D 18316149 10.1016/j.pnpbp.2008.01.006 (Pubitemid 352033661)
6. I Fingiel 2008 Pro-inflammatory cytokine TNF-α as a neuroprotective agent in the brain Acta Neurobiol Exp 68 526 534
7. D Aderka 1996 The potential biological and clinical significance of the soluble tumor necrosis factor receptors Cytokine Growth Factor Rev 7 231 240 1:CAS:528:DyaK2sXht1Sk 8971478 10.1016/S1359-6101(96)00026-3 (Pubitemid 27200307)
8. M Kauer-Sant'anna F Kapczinski AC Andreazza DJ Bond RW Lam LT Young LN Yatham 2009 Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder Int J Neuropsychopharmacol 12 4 447 458 18771602 10.1017/S1461145708009310
9. SM O'Brien P Scully LV Scott TG Dinan 2006 Cytokine profiles in bipolar affective disorder: focus on acutely ill patients J Affect Disord 90 263 267 16410025 10.1016/j.jad.2005.11.015 (Pubitemid 43183536)
10. A Ortiz-Domínguez ME Hernández C Berlanga D Gutiérrez-Mora J Moreno G Heinze L Pavón 2007 Immune variations in bipolar disorder: phasic differences Bipolar Disord 9 596 602 17845274 10.1111/j.1399-5618.2007.00493.x (Pubitemid 47365627)
11. YK Kim HG Jung AM Myint H Kim SH Park 2007 Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder J Affect Disord 104 91 95 1:CAS:528:DC%2BD2sXht12ns7vN 17434599 10.1016/j.jad.2007.02.018 (Pubitemid 350064526)
12. YJ Hung CH Hsieh YJ Chen D Pei SW Kuo DC Shen WH Shen YC Chen 2007 Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder Clin Endocrinol (Oxf) 67 5 784 789 1:CAS:528:DC%2BD2sXhtlOhs7vI 10.1111/j.1365-2265.2007.02963.x (Pubitemid 47628469)
13. E Brietzke L Stertz BS Fernandes M Kauer-Sant'anna M Mascarenhas A Escosteguy Vargas JÁ Chies F Kapczinski 2009 Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder J Affect Disord 116 3 214 217 1:CAS:528:DC%2BD1MXnsV2qtr0%3D 19251324 10.1016/j.jad.2008.12.001
14. Z Kronfol DG Remick 2000 Cytokines and the brain: implications for clinical psychiatry Am J Psychiatry 157 683 694 1:STN:280:DC%2BD3c3ks12itw%3D%3D 10784457 10.1176/appi.ajp.157.5.683 (Pubitemid 30249643)
15. H Himmerich S Fulda J Linseisen H Seiler G Wolfram S Himmerich K Gedrich S Kloiber S Lucae M Ising M Uhr F Holsboer T Pollmächer 2008 Depression, comorbidities and the TNF-alpha system Eur Psychiatry 23 6 421 429 1:STN:280:DC%2BD1cngtVWjtg%3D%3D 18504118 10.1016/j.eurpsy.2008.03.013
16. R Grassi-Oliveira E Brietzke JC Pezzi RP Lopes AL Teixeira ME Bauer 2009 Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder Psychiatry Clin Neuroci 63 202 208 1:CAS:528: DC%2BD1MXlsFOnsrY%3D 10.1111/j.1440-1819.2008.01918.x
17. FM Coelho HJ Reis R Nicolato MA Romano-Silva MM Teixeira ME Bauer AL Teixeira 2008 Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia Neuroimmunomodulation 15 2 140 144 1:CAS:528:DC%2BD1cXhtVejsL%2FP 18679053
18. P Scalzo A Kummer F Cardoso AL Teixeira 2009 Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease J Neuroimmunol 216 1-2 122 125 1:CAS:528:DC%2BD1MXhsVajs7%2FF 19732964 10.1016/j.jneuroim.2009.08.001
19. DV Sheehan Y Lecrubier KH Sheehan P Amorim J Janavs E Weiller T Hergueta R Baker GC Dunbar 1998 The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 4 57
20. RC Young JT Biggs VE Ziegler DA Meyer 1978 A rating scale for mania: reliability, validity and sensitivity Br J Psychiatry 133 429 435 1:STN:280:DyaE1M%2FotlCktQ%3D%3D 728692 10.1192/bjp.133.5.429 (Pubitemid 9006756)
21. M Hamilton 1976 Development of a rating scale for primary depressive illness Br J Soc Clin Psychol 6 278 296
22. LJ Byer 2008 An evidence-based medicine strategy for achieving remission in bipolar disorder J Clin Psychiatry 69 31 37 10.4088/JCP.1108e31
23. H Himmerich D Koethe A Schuld A Yassouridis T Pollmächer 2005 Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium Psychopharmacology (Berl) 179 2 447 451 1:CAS:528:DC%2BD2MXjtV2iu70%3D 10.1007/s00213-004-2038-9 (Pubitemid 40569047)
24. M Haack D Hinze-Selch T Fenzel T Kraus M Kühn A Schuld T Pollmächer 1999 Plasma levels of cytokines and soluble cytokines receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis J Psychiatr Res 33 5 407 418 1:STN:280:DyaK1MvjtFegtg%3D%3D 10504009 10.1016/S0022-3956(99)00021-7 (Pubitemid 29392689)
25. B Dean N Tawadros E Scarr AS Gibbons 2010 Regionally-specific changes in levels of tumor necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder J Affect Disord 120 245 248 1:CAS:528:DC%2BD1MXhsFGru7rI 19446343 10.1016/j.jad.2009.04.027
26. H Hauner M Bender B Haastert F Hube 1998 Plasma concentrations of soluble TNF-alpha receptors in obese subjects Int J Obes Relat Metab Disord 22 12 1239 1243 1:STN:280:DyaK1M%2FptlSrug%3D%3D 9877261 10.1038/sj.ijo.0800773 (Pubitemid 28548546)